COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 2263: Articles 22621-22630  | Next

High affinity modified ACE2 receptors prevent SARS-CoV-2 infection
Higuchi, Y., Suzuki, T., Arimori, T., Ikemura, N., Kirita, Y., Ohgitani, E., Mazda, O., Motooka, D., Nakamura, S., Matsuura, Y., Matoba, S., Okamoto, T., Takagi, J., Hoshino, A.
10.1101/2020.09.16.299891 — Posted: 2020-09-16 Discussion: Onsite | Offsite
Variation across population subgroups of COVID-19 antibody testing performance
Brantley, H. L., Yoo, R. M., Jones, G. I., Stock, M. A., Park, P. J., Sheils, N. E., Kohane, I. S.
10.1101/2020.09.14.20191833 — Posted: 2020-09-16
Nowcasting CoVID-19 Deaths in England by Age and Region
Seaman, S., Samartsidis, P., Kall, M., De Angelis, D.
10.1101/2020.09.15.20194209 — Posted: 2020-09-16
The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: A population-based study
Leon-Abarca, J. A., Memon, R. S., Rehan, B., Iftikhar, M., Chatterjee, A.
10.1101/2020.09.12.20193235 — Posted: 2020-09-16
SARS-CoV-2 protein Nsp1 alters actomyosin cytoskeleton and phenocopies arrhythmogenic cardiomyopathy-related PKP2 mutant
Marquez-Lopez, C., Roche-Molina, M., Garcia-Quintans, N., Sacristan, S., Siniscalco, D., Gonzalez-Guerra, A., Camafeita, E., Lytvyn, M., Guillen, M. I., Sanz-Rosa, D., Martin-Perez, D., Sanchez-Ramos, C., Garcia, R., Bernal, J. A.
10.1101/2020.09.14.296178 — Posted: 2020-09-16
Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19
Carvallo, H. E., Hirsch, R. R., Farinella, M. E.
10.1101/2020.09.10.20191619 — Posted: 2020-09-15 Discussion: Onsite
CROssBAR: Comprehensive Resource of Biomedical Relations with Deep Learning Applications and Knowledge Graph Representations
Dogan, T., Atas, H., Joshi, V., Atakan, A., Rifaioglu, A. S., Nalbat, E., Nightingale, A., Saidi, R., Volynkin, V., Zellner, H., Cetin-Atalay, R., Martin, M., Atalay, V.
10.1101/2020.09.14.296889 — Posted: 2020-09-15
Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
Westberg, M., Su, Y., Zou, X., Hurst, B., Tarbet, B., Lin, M.
10.1101/2020.09.15.275891 — Posted: 2020-09-15 Discussion: Onsite
LOX-1+ immature neutrophils predict severe COVID-19 patients at risk of thrombotic complications
Combadiere, B., Adam, L., Quentric, P., Rosenbaum, P., Dorgham, K., Bonduelle, O., Parizot, C., Sauce, D., Mayaux, J., Luyt, C.-E., Boissonnas, A., Amoura, Z., Pourcher, V., Miyara, M., Gorochov, G., Guihot, A., Combadiere, C.
10.1101/2020.09.15.293100 — Posted: 2020-09-15
SARS-CoV-2 ribosomal frameshifting pseudoknot: Improved secondary structure prediction and detection of inter-viral structural similarity
Trinity, L., Lansing, L., Jabbari, H., Stege, U.
10.1101/2020.09.15.298604 — Posted: 2020-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).